|
1
|
Marin-Garcia J, Ananthakrishnan R,
Goldenthal MJ, Filiano JJ and Perez-Atayde A: Cardiac mitochondrial
dysfunction and DNA depletion in children with hypertrophic
cardiomyopathy. J Inherit Metab Dis. 20:674–680. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scaglia F, Towbin JA, Craigen WJ, et al:
Clinical spectrum, morbidity, and mortality in 113 pediatric
patients with mitochondrial disease. Pediatrics. 114:925–931. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Erdmann J, Daehmlow S, Wischke S, et al:
Mutation spectrum in a large cohort of unrelated consecutive
patients with hypertrophic cardiomyopathy. Clin Genet. 64:339–349.
2001. View Article : Google Scholar
|
|
4
|
Richard P, Charron P, Carrier L, et al:
Distribution of disease genes in 102 genotyped families with
hypertrophic cardiomyopathy. Circulation. 104:521. 2001.
|
|
5
|
Sachdev B, Takenaka T, Teraguchi H, Tei C,
Lee P, McKenna WJ and Elliott PM: Prevalence of Anderson-Fabry
disease in male patients with late onset hypertrophic
cardiomyopathy. Circulation. 105:1407–1411. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Patra S, Subramaniun A, Mahimaiha J,
Sastry UM and Nanjappa MC: Apical hypertrophic cardiomyopathy in an
infant: first presentation of pompe's disease. World J Pediatr
Congenit Heart Surg. 5:491–493. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moak JP and Kaski JP: Hypertrophic
cardiomyopathy in children. Heart. 98:1044–1054. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marian AF and Roberts R: The molecular
genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol.
33:655–670. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seidman CE, Seidman JG, InScriver CR, et
al: The Metabolic and Molecular Basis of Inherited Disease. pp.
433–5418. 2001
|
|
10
|
Xu Q, Dewey S, Nguyen S and Gomes AV:
Malignant and benign mutations in familial cardiomyopathies:
Insights into mutations linked to complex cardiovascular
phenotypes. J Mol Cell Cardiol. 48:899–909. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Howell RR, Byrne B, Darras BT, Kishnani P,
Nicolino M and van der Ploeg A: Diagnostic challenges for Pompe
disease: an under-recognized cause of floppy baby syndrome. Genet
Med. 8:289–296. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lalani SR, Thakuria JV, Cox GF, et al:
20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome
with variable neurocognitive deficits. J Med Genet. 46:168–175.
2009. View Article : Google Scholar :
|
|
13
|
Jay PY, Harris BS, Maguire CT, et al:
Nkx2–5 mutation causes anatomic hypoplasia of the cardiac
conduction system. J Clin Invest. 113:1130–1137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishino I, Fu J, Tanji K, et al: Primary
LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and
myopathy (Danon disease). Nature. 406:906–910. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tartaglia M, Mehler EL, Goldberg R, et al:
Mutations in PTPN11, encoding the protein tyrosine phosphatase
SHP-2, cause Noonan syndrome. Nat Genet. 29:465–468. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tartaglia M, Pennacchio LA, Zhao C, et al:
Gain-of-function SOS1 mutations cause a distinctive form of Noonan
syndrome. Nat Genet. 39:75–79. 2007. View
Article : Google Scholar
|
|
17
|
Schubbert S, Zenker M, Rowe SL, et al:
Germline KRAS mutations cause Noonan syndrome. Nat Genet.
38:331–336. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Metzker ML: Sequencing technologies-the
next generation. Nat Rev Genet. 11:31–46. 2010. View Article : Google Scholar
|
|
19
|
Mamanova L, Coffey AJ, Scott CE, et al:
Target-enrichment strategies for next-generation sequencing. Nat
Methods. 7:111–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Schmidt B and Maskell DL: CUSHAW: a
CUDA compatible short read aligner to large genomes based on the
Burrows-Wheeler transform. Bioinformatics. 28:1830–1837. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li H, Handsaker B, Wysoker A, et al: The
sequence alignment/map format and SAMtools. Bioinformatics.
25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gollob MH, Green MS, Tang AS and Roberts
R: PRKAG2 cardiac syndrome: Familial ventricular preexcitation,
conduction system disease and cardiac hypertrophy. Curr Opin
Cardiol. 17:229–234. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fitzsimmons PJ, McWhirter PD, Peterson DW
and Kruyer WB: The natural history of Wolff-Parkinson-White
syndrome in 228 military aviators: A long-term follow-up of 22
years. Am Heart J. 142:530–536. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gollb MH, Green MS, Tang AS, et al:
Identification of a gene responsible for familial
Wolff-Parkinson-White syndrome. N Engl J Med. 344:1823–1831. 2001.
View Article : Google Scholar
|
|
25
|
Zhang BL, Ye Z, Xu RL, et al:
Overexpression of G100S mutation in PRKAG2 causes
Wolff-Parkinson-White syndrome in zebrafish. Clin Genet.
86:287–291. 2014. View Article : Google Scholar
|
|
26
|
Sidhu JS, Rajawat YS, Rami TG, et al:
Transgenic mouse model of ventricular preexeitation and
atrioventricular reentrant achycardia induced by an AMP-activated
protein kinase loss-of-function mutation responsible for
Wolff-Parkinson-White syndrome. Circulation. 111:21–29. 2005.
View Article : Google Scholar
|
|
27
|
Tan HL, van der Wal AC, Campian ME, et al:
Nodoventricular accessory pathways in PRKAG2-dependent familial
preexcitation syndrome reveal a disorder in cardiac development.
Circ Arrhythm Electrophysiot. 1:276–281. 2008. View Article : Google Scholar
|
|
28
|
Douglas SA, Tayara L, Ohlstein EH, Halawaa
N and Giaid A: Congestive heart failure and expression of
myocardial urotensin II. Lancet. 359:1990–1997. 2002. View Article : Google Scholar : PubMed/NCBI
|
